Glazer Capital »

Amicus Therapeutics shares owned by Glazer Capital

Quarter-by-quarter ownership of Amicus Therapeutics (FOLD) shares owned by Glazer Capital from 13F filings

Historical chart of Glazer Capital investment in Amicus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Amicus Therapeutics held by Glazer Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amicus Therapeutics by Glazer Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $23M 1.6M 14.24

More positions owned by Glazer Capital

Ceridian Hcm Hldg
Cyberark Software SHS (CYBR)
Avidity Biosciences Ord (RNA)
EXACT Sciences Corporation (EXAS)
Air Lease Corp Cl A (AL)
Comerica Incorporated
Cidara Therapeutics Com New (CDTX)
Brighthouse Finl (BHF)
Electronic Arts (EA)
Cadence Bank
Clearwater Analytics Hldgs I Cl A (CWAN)
Bentley Sys Note 0.00125 1/1 (Principal)
Sealed Air (SEE)
Marriott Vacations Worldwide Note 1/1 (Principal)
Dropbox Note 3/0 (Principal)

View all positions for Glazer Capital

Top funds holding Amicus Therapeutics

BlackRock
Vanguard Group
Wellington Management Company
State Street Corporation
Millennium Management
Bellevue Group
William Blair Investment Management
Citadel Advisors
Geode Capital Management
Perceptive Advisors
Goldman Sachs Group
UBS Group
Palo Alto Investors
Soleus Capital Management
Soros Fund Management

View all funds holding Amicus Therapeutics